Nachman Shlomo 4

What Happened

• Nachman Shlomo, a director of AtriCure, was granted 6,144 restricted shares on May 18, 2026. The grant price is listed as $0.00, so the immediate cash value reported in the Form 4 is $0. These shares are an equity award (code A), not a purchase or sale.

Key Details

• Transaction date: 2026-05-18; Form 4 filed: 2026-05-20.
• Grant: 6,144 restricted shares at $0.00 per share (total reported value $0).
• Shares owned after transaction: not specified in the provided filing summary.
• Footnote: The shares were issued under the AtriCure, Inc. 2023 Stock Incentive Plan and will vest on the one-year anniversary of the grant date (i.e., vesting on 2027-05-18) (F1).
• Filing timeliness: no late-filing flag indicated in the provided information.

Context

• Restricted stock awards are common director compensation and vesting means the shares become fully owned only after the vesting date; until then they may be forfeitable. This was a grant (not a sale or open-market purchase), so it does not directly signal a buy or sell decision by the insider.